The previous ten years of research had indicated a tremendous promise for the therapeutic uses of natural cannabis, and this potential was quietly turned over to corporate hands - not for the benefit of the public, but to suppress the medical information. This plan, the drug manufacturers petitioned, would allow our private drug companies time to come up with patentable synthetics of the cannabis molecules at no cost to the federal government, and a promise of "no highs." lowryder seeds In 1976, the Ford Administration, NIDA and the DEA said in effect, no American independent (read: university) research or federal health program would be allowed to again investigate natural cannabis derivatives for medicine.

There are no comments to this entry.